马莱胺功能化多拉克小粒用于谷氨酸灭和多克索鲁比输送
Godwin K Babanyinah1, Abhi Bhadran1, Himanshu Polara1
1Department of Chemistry and Biochemistry, University of Texas at Dallas Richardson TX USA mihaela@utdallas.edu.
Chemical science
|July 5, 2024
概括
这项研究引入了新的maleimide功能化聚烯酸聚合物,用于降低癌细胞中的谷氨水平,增强氧化应激并促进细胞死亡. 发育的细胞有效地输送多克索鲁比,显示出显著的抗癌活性.
科学领域:
- 生物材料科学 生物材料科学
- 癌症生物学 癌症生物学
- 药物输送系统 药物输送系统
背景情况:
- 较高的谷氨水平使得癌细胞在氧化压力下能够存活.
- 向谷氨可以加剧氧化应激,并诱导癌细胞亡.
- 聚烯酸 (PCL) 为生物医学应用提供可生物降解和生物相容性质.
研究的目的:
- 开发新的maleimide功能化的聚氨酸聚合物 (PCL) 聚合物,用于癌细胞中的谷氨耗尽.
- 创建基于PCL的聚合物微粒,用于向癌症治疗.
- 为了评估药物加载,释放和细胞毒性,开发的细胞.
主要方法:
- 使用PEG作为宏观启动剂合成两类块共聚物.
- 结合2,3-二二多多胺胺的功能性到PCL.
- 聚合物微粒的形成和多克索鲁比 (DOX) 的加载.
- 评估谷氨的火,药物释放动力学和体外细胞毒性.
主要成果:
- 在低度下,2,3-二二多多胺胺结合的PCL微粒有效地灭了谷氨.
- 装载DOX的菌体表现出依赖pH的药物释放,具有很高的负载能力 (3.5%).
- 与空微粒相比,DOX载荷的微粒对癌细胞表现出更高的细胞毒性.
结论:
- 马莱胺功能化PCL聚合物显示出在癌细胞中消耗细胞内谷氨 (GSH) 的潜力.
- 开发的DOX载小粒体代表了提高癌症治疗疗效的潜在策略.
- 这种方法通过向癌细胞防御机制,提供了一种新的治疗途径.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


